Johnson & Johnson stock (NYSE: JNJ) lost about 7% in 2024, underperforming the broader S&P 500 index, which gained 23% for ...

NEW BRUNSWICK, N.J., December 10, 2024--Johnson & Johnson (NYSE: JNJ) will host a conference call for investors at 8:00 a.m. (Eastern Time) on Wednesday, January 22nd to review fourth-quarter results.

Investors in Johnson & Johnson (Symbol: JNJ) saw new options become available today, for the February 2025 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.

Shares of Johnson & Johnson are flat in Monday's trading. But they continue to test support. If this support breaks, it could be bearish for the entire market. Mark Putrino Marjorie Taylor Greene ...

Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments ...

Johnson & Johnson’s JNJ MedTech unit has temporarily paused sales of Varipulse, its pulsed field ablation (PFA) therapy to ...

Johnson & Johnson closed $26.58 below its 52-week high ($168.85), which the company reached on September 4th.